Advertisement
Screener

XBIOTECH INC. (XBIT) Stock-Based Compensation

2.8 / 5 stars · 68/120 Roast Me

XBIOTECH INC. Stock-Based Compensation

XBIOTECH INC. (XBIT) reported Stock-Based Compensation of $344.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.

Financial Statements › Cash Flow › Operating Activities

us-gaap:ShareBasedCompensation · last filed 2026-08-13

  • XBIOTECH INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $172.00K, a 60.75% increase year-over-year.
  • XBIOTECH INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $172.00K, a 94.83% decline year-over-year.
  • XBIOTECH INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $162.00K, a 74.20% decline year-over-year.
  • XBIOTECH INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $24.00K, a 93.42% decline year-over-year.
  • XBIOTECH INC. share-based payment arrangement, noncash expense for fiscal 2025 was $3.62M, a 106.62% increase from fiscal 2024.
  • XBIOTECH INC. share-based payment arrangement, noncash expense for fiscal 2024 was $1.75M, a 46.26% decline from fiscal 2023.
  • XBIOTECH INC. share-based payment arrangement, noncash expense for fiscal 2023 was $3.26M, a 35.56% decline from fiscal 2022.
  • XBIOTECH INC. share-based payment arrangement, noncash expense for fiscal 2022 was $5.06M, a 13.42% increase from fiscal 2021.
Period endShare-based Payment Arrangement, Noncash Expense 3 monthShare-based Payment Arrangement, Noncash Expense 6 monthShare-based Payment Arrangement, Noncash Expense 9 monthShare-based Payment Arrangement, Noncash Expense 12 month
2026-06-30$172.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13
$344.00K
10-Q · filed 2026-08-13
$506.00K
derived: sum of 3 quarters · filed 2026-08-13
$530.00K
derived: sum of 4 quarters · filed 2026-08-13
2026-03-31$172.00K
10-Q · filed 2026-05-14
$334.00K
derived: sum of 2 quarters · filed 2026-05-14
$358.00K
derived: sum of 3 quarters · filed 2026-05-14
$465.00K
derived: sum of 4 quarters · filed 2026-08-13
2025-12-31$162.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13
$186.00K
derived: sum of 2 quarters · filed 2026-03-13
$293.00K
derived: sum of 3 quarters · filed 2026-08-13
$3.62M
10-K · filed 2026-03-13
2025-09-30$24.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12
$131.00K
derived: sum of 2 quarters · filed 2026-08-13
$3.46M
10-Q · filed 2025-11-12
$4.09M
derived: sum of 4 quarters · filed 2026-08-13
2025-06-30$107.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13
$3.44M
10-Q · filed 2026-08-13
$4.06M
derived: sum of 3 quarters · filed 2026-08-13
$4.43M
derived: sum of 4 quarters · filed 2026-08-13
2025-03-31$3.33M
10-Q · filed 2026-05-14
$3.96M
derived: sum of 2 quarters · filed 2026-05-14
$4.32M
derived: sum of 3 quarters · filed 2026-05-14
$4.70M
derived: sum of 4 quarters · filed 2026-05-14
2024-12-31$628.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13
$993.00K
derived: sum of 2 quarters · filed 2026-03-13
$1.37M
derived: sum of 3 quarters · filed 2026-03-13
$1.75M
10-K · filed 2026-03-13
2024-09-30$365.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12
$744.00K
derived: sum of 2 quarters · filed 2025-11-12
$1.13M
10-Q · filed 2025-11-12
$1.81M
derived: sum of 4 quarters · filed 2025-11-12
2024-06-30$379.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13
$760.00K
10-Q · filed 2025-08-13
$1.45M
derived: sum of 3 quarters · filed 2025-08-13
$2.40M
derived: sum of 4 quarters · filed 2025-08-13
2024-03-31$381.00K
10-Q · filed 2025-05-14
$1.07M
derived: sum of 2 quarters · filed 2025-05-14
$2.02M
derived: sum of 3 quarters · filed 2025-05-14
$2.94M
derived: sum of 4 quarters · filed 2025-05-14
2023-12-31$688.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18
$1.64M
derived: sum of 2 quarters · filed 2025-03-18
$2.56M
derived: sum of 3 quarters · filed 2025-03-18
$3.26M
10-K · filed 2025-03-18
2023-09-30$955.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13
$1.87M
derived: sum of 2 quarters · filed 2024-11-13
$2.57M
10-Q · filed 2024-11-13
$3.61M
derived: sum of 4 quarters · filed 2024-11-13
2023-06-30$914.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12
$1.62M
10-Q · filed 2024-08-12
$2.66M
derived: sum of 3 quarters · filed 2024-08-12
$3.79M
derived: sum of 4 quarters · filed 2024-08-12
2023-03-31$705.00K
10-Q · filed 2024-05-10
$1.74M
derived: sum of 2 quarters · filed 2024-05-10
$2.87M
derived: sum of 3 quarters · filed 2024-05-10
$4.32M
derived: sum of 4 quarters · filed 2024-05-10
2022-12-31$1.04M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15
$2.17M
derived: sum of 2 quarters · filed 2024-03-15
$3.61M
derived: sum of 3 quarters · filed 2024-03-15
$5.06M
10-K · filed 2024-03-15
2022-09-30$1.13M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09
$2.58M
derived: sum of 2 quarters · filed 2023-11-09
$4.02M
10-Q · filed 2023-11-09
$5.38M
derived: sum of 4 quarters · filed 2023-11-09
2022-06-30$1.45M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11
$2.90M
10-Q · filed 2023-08-11
$4.25M
derived: sum of 3 quarters · filed 2023-08-11
$5.38M
derived: sum of 4 quarters · filed 2023-08-11
2022-03-31$1.45M
10-Q · filed 2023-05-10
$2.80M
derived: sum of 2 quarters · filed 2023-05-10
$3.94M
derived: sum of 3 quarters · filed 2023-05-10
$4.97M
derived: sum of 4 quarters · filed 2023-05-10
2021-12-31$1.35M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15
$2.49M
derived: sum of 2 quarters · filed 2023-03-15
$3.53M
derived: sum of 3 quarters · filed 2023-03-15
$4.46M
10-K · filed 2023-03-15
2021-09-30$1.13M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09
$2.17M
derived: sum of 2 quarters · filed 2022-11-09
$3.11M
10-Q · filed 2022-11-09
$5.90M
derived: sum of 4 quarters · filed 2022-11-09
2021-06-30$1.04M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10
$1.98M
10-Q · filed 2022-08-10
$4.77M
derived: sum of 3 quarters · filed 2022-08-10
$7.93M
derived: sum of 4 quarters · filed 2022-08-10
2021-03-31$936.00K
10-Q · filed 2022-05-10
$3.73M
derived: sum of 2 quarters · filed 2022-05-10
$6.89M
derived: sum of 3 quarters · filed 2022-05-10
$10.06M
derived: sum of 4 quarters · filed 2022-05-10
2020-12-31$2.79M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15
$5.95M
derived: sum of 2 quarters · filed 2022-03-15
$9.13M
derived: sum of 3 quarters · filed 2022-03-15
$12.58M
10-K · filed 2022-03-15
2020-09-30$3.16M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09
$6.33M
derived: sum of 2 quarters · filed 2021-11-09
$9.79M
10-Q · filed 2021-11-09
$11.29M
derived: sum of 4 quarters · filed 2022-03-15
2020-06-30$3.17M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09
$6.63M
10-Q · filed 2021-08-09
$8.14M
derived: sum of 3 quarters · filed 2022-03-15
$8.93M
derived: sum of 4 quarters · filed 2022-03-15
2020-03-31$3.46M
10-Q · filed 2021-05-10
$4.96M
derived: sum of 2 quarters · filed 2022-03-15
$5.76M
derived: sum of 3 quarters · filed 2022-03-15
$6.24M
derived: sum of 4 quarters · filed 2022-03-15
2019-12-31$1.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15
$2.30M
derived: sum of 2 quarters · filed 2022-03-15
$2.79M
derived: sum of 3 quarters · filed 2022-03-15
$3.36M
10-K · filed 2022-03-15
2019-09-30$797.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09
$1.28M
derived: sum of 2 quarters · filed 2020-11-09
$1.85M
10-Q · filed 2020-11-09
$2.33M
derived: sum of 4 quarters · filed 2021-03-16
2019-06-30$486.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10
$1.06M
10-Q · filed 2020-08-10
$1.53M
derived: sum of 3 quarters · filed 2021-03-16
$1.97M
derived: sum of 4 quarters · filed 2021-03-16
2019-03-31$570.00K
10-Q · filed 2020-05-11
$1.04M
derived: sum of 2 quarters · filed 2021-03-16
$1.48M
derived: sum of 3 quarters · filed 2021-03-16
$2.12M
derived: sum of 4 quarters · filed 2021-03-16
2018-12-31$474.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16
$913.00K
derived: sum of 2 quarters · filed 2021-03-16
$1.55M
derived: sum of 3 quarters · filed 2021-03-16
$1.66M
10-K · filed 2021-03-16
2018-09-30$439.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12
$1.08M
derived: sum of 2 quarters · filed 2019-11-12
$1.19M
10-Q · filed 2019-11-12
$1.60M
derived: sum of 4 quarters · filed 2020-03-16
2018-06-30$637.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09
$747.00K
10-Q · filed 2019-08-09
$1.16M
derived: sum of 3 quarters · filed 2020-03-16
$1.60M
derived: sum of 4 quarters · filed 2020-03-16
2018-03-31$110.00K
10-Q · filed 2019-05-09
$520.00K
derived: sum of 2 quarters · filed 2020-03-16
$964.00K
derived: sum of 3 quarters · filed 2020-03-16
$1.14M
derived: sum of 4 quarters · filed 2020-03-16
2017-12-31$410.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16
$854.00K
derived: sum of 2 quarters · filed 2020-03-16
$1.03M
derived: sum of 3 quarters · filed 2020-03-16
$1.75M
10-K · filed 2020-03-16
2017-09-30$444.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31
$616.00K
derived: sum of 2 quarters · filed 2018-10-31
$1.34M
10-Q · filed 2018-10-31
$2.87M
derived: sum of 4 quarters · filed 2019-03-15
2017-06-30$172.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09
$896.00K
10-Q · filed 2018-08-09
$2.43M
derived: sum of 3 quarters · filed 2019-03-15
$3.56M
derived: sum of 4 quarters · filed 2019-03-15
2017-03-31$724.00K
10-Q · filed 2018-05-08
$2.26M
derived: sum of 2 quarters · filed 2019-03-15
$3.38M
derived: sum of 3 quarters · filed 2019-03-15
$4.48M
derived: sum of 4 quarters · filed 2019-03-15
2016-12-31$1.53M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-03-15
$2.66M
derived: sum of 2 quarters · filed 2019-03-15
$3.76M
derived: sum of 3 quarters · filed 2019-03-15
$5.57M
10-K/A · filed 2019-03-15
2016-09-30$1.13M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09
$2.22M
derived: sum of 2 quarters · filed 2017-11-09
$4.04M
10-Q · filed 2017-11-09
$5.09M
derived: sum of 4 quarters · filed 2018-03-16
2016-06-30$1.10M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08
$2.91M
10-Q · filed 2017-08-08
$3.97M
derived: sum of 3 quarters · filed 2018-03-16
$4.85M
derived: sum of 4 quarters · filed 2018-03-16
2016-03-31$1.82M
10-Q · filed 2017-05-10
$2.87M
derived: sum of 2 quarters · filed 2018-03-16
$3.75M
derived: sum of 3 quarters · filed 2018-03-16
$5.00M
derived: sum of 4 quarters · filed 2018-03-16
2015-12-31$1.05M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16
$1.94M
derived: sum of 2 quarters · filed 2018-03-16
$3.19M
derived: sum of 3 quarters · filed 2018-03-16
$4.41M
10-K · filed 2018-03-16
2015-09-30$886.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14
$2.13M
derived: sum of 2 quarters · filed 2016-11-14
$3.35M
10-Q · filed 2016-11-14
$5.40M
derived: sum of 4 quarters · filed 2017-03-16
2015-06-30$1.25M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-12
$2.47M
10-Q · filed 2016-08-12
$4.52M
derived: sum of 3 quarters · filed 2017-03-16
$7.04M
derived: sum of 4 quarters · filed 2017-03-16
2015-03-31$1.22M
10-Q · filed 2016-05-13
$3.27M
derived: sum of 2 quarters · filed 2017-03-16
$5.79M
derived: sum of 3 quarters · filed 2017-03-16
$6.40M
derived: sum of 4 quarters · filed 2017-03-16
2014-12-31$2.05M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16
$4.57M
derived: sum of 2 quarters · filed 2017-03-16
$5.18M
derived: sum of 3 quarters · filed 2017-03-16
$7.02M
10-K · filed 2017-03-16
2014-09-30$2.52M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13
$3.13M
derived: sum of 2 quarters · filed 2015-11-13
$4.97M
10-Q · filed 2015-11-13
2014-06-30$606.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-14
$2.45M
10-Q · filed 2015-08-14
2014-03-31$1.84M
10-Q · filed 2015-06-18
2013-12-31$739.00K
10-K · filed 2016-04-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
HYPERION DEFI, INC. (HYPD)United States$0.065B
Rein Therapeutics, Inc. (RNTX)United States$0.063B-1.76
Connect Biopharma Holdings Ltd (CNTB)$0.069B-2.17
Yarrow Bioscience, Inc. (YARW)United States$0.070B
Skye Bioscience, Inc. (SKYE)United States$0.061B-0.48
PLIANT THERAPEUTICS, INC. (PLRX)United States$0.071B-0.76
TENAX THERAPEUTICS, INC. (TENX)United States$0.071B-7.17
CalciMedica, Inc. (CALC)United States$0.061B-1.42
TALPHERA, INC. (TLPH)United States$0.060B
PMV Pharmaceuticals, Inc. (PMVP)United States$0.071B-0.95